Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-25T11:03:25.993Z Has data issue: false hasContentIssue false
  • English
  • Français

Suppression of Bulimic Symptoms with Methylamphetamine

Published online by Cambridge University Press:  29 January 2018

Yong Lock Ong ,
Stuart A. Checkley  and
G. F. M. Russell
Yong Lock Ong
Affiliation:
Department of Psychological Medicine, The Institute of Psychiatry and the Maudsley Hospital, Denmark Hill, London SE5 8AF
Stuart A. Checkley
Affiliation:
The Institute of Psychiatry and the Maudsley Hospital, Denmark Hill, London SE5 8AF
G. F. M. Russell
Affiliation:
The Institute of Psychiatry and the Maudsley Hospital, Denmark Hill, London SE5 8AF
Get access Rights & Permissions [Opens in a new window]

Summary

Eight patients with bulimia nervosa were given methylamphetamine or placebo intravenously under double blind controlled conditions. In every patient, methylamphetamine reduced self-ratings of hunger and amount of food eaten as measured under laboratory conditions. This shows that the food intake of patients with bulimia nervosa can be modified by experimental drugs. The symptom of bulimia (rapid, excessive and distressing eating) which may be followed by self-induced vomiting or purgation was seen in four patients after receiving placebo but in none after receiving methylamphetamine. These findings suggest that the severe symptom of bulimia may be amenable to drug treatment. Further studies are needed to explore the mechanism by which methylamphetamine appears to prevent bulimia.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 143 , Issue 3 , September 1983 , pp. 288 - 293
Copyright
Copyright © 1983 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Angrist, B. & Sudilovsky, A. (1978) Central nervous system stimulants: historical aspects and clinical effects. In Handbook of Psychopharmacology, Volume II (eds. Iversen, L. L., Iversen, S. D. and Snyder, S. H., pp.99–165. New York: Plenum.Google Scholar
Casper, R. C., Eckert, E. D., Halmi, K. A., Goldberg, S. C. & Davis, J. M. (1980) Bulimia: its incidence and clinical importance in patients with anorexia nervosa. Archives of General Psychiatry, 37, 1030–5.Google Scholar
Checkley, S. A. (1982) The psychostimulants. In Drugs in Psychiatric Practice (eds. Mackay, A. V. P. and Tyrer, P. J.). London: Butterworths.Google Scholar
Checkley, S. A. & Crammer, J. L. (1977) Hormone responses to methylamphetamine in depression. A new approach to the noradrenaline depletion hypothesis. British Journal of Psychiatry, 131, 582–86.Google Scholar
Connell, P. H. (1975) Central nervous system stimulants. In Mayler's Side Effects of Drugs. (ed. Dukes, M. N. G.) Amsterdam and Oxford: Excerpta Medica.Google Scholar
Fairburn, C. G. (1980) Self-induced vomiting. Journal of Psychosomatic Research, 24, 193–7.Google Scholar
Garfinkel, P. E., Moldofsky, H. & Garner, D. M. (1980) The heterogeneity of anorexia nervosa: Bulimia as a distinct subgroup. Archives of General Psychiatry, 37, 1036–40.Google Scholar
Green, R. S. & Rau, J. H. (1977) The use of diphenylhydantoin in compulsive eating disorders: further studies. In Anorexia Nervosa (ed. Vigersky, R. A.), pp. 377–382. New York: Raven Press.Google Scholar
Nogami, Y. & Yabana, F. (1977) On Kibarashi-gui (binge-eating) Folia Psychiatrica et Neurologica Japonica, 31, 2, 156–66.Google ScholarPubMed
Pyle, R. L., Mitchell, M. D. & Eckert, E. D. (1981) Bulimia: a report of 34 cases. Journal of Clinical Psychiatry, 42, 60–4.Google Scholar
Russell, G. F. M. (1979) Bulimia Nervosa: an ominous variant of anorexia nervosa. Psychological Medicine, 9, 429–48.Google Scholar
Sabine, E., Yonace, A., Farrington, A. J., Barratt, K. H. & Wakeling, A. (1983) Bulimia nervosa: a placebo-controlled double-blind therapeutic trial of mianserin. In Proceedings of the Second Symposium on Mianserin. British Journal of Clinical Pharmacology Suppl. 2, 15, 195S–202S.Google ScholarPubMed
Wardle, J. & Beinhart, H. (1981) Binge eating: a theoretical review. British Journal of Clinical Psychology, 20, 2, 97–109.Google Scholar
Wermuth, B. M., Davis, K. L., Hollister, L. E. & Stunkard, A. J. (1977) Phenytoin treatment of the binge-eating syndrome. American Journal of Psychiatry, 134, 11, 1249–53.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.